| Medical and Health Sciences | Lifetime | 482 | US 262 | 99.98 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 25 | US 11 | 99.90 |
| Medical Physiology | Lifetime | 130 | US 74 | 99.81 |
| Molecular Biology | Lifetime | 602 | US 370 | 99.70 |
| Pulmonary and Respiratory Medicine | Lifetime | 906 | US 469 | 98.52 |
| Cell Biology | Lifetime | 631 | US 346 | 96.34 |
| Clinical Pharmacology | Lifetime | 964 | US 413 | 95.40 |
| Clinical Biochemistry | Lifetime | 586 | US 254 | 88.27 |
| Nephrology | Lifetime | 771 | US 355 | 88.38 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 171 | US 79 | 97.05 |
| Metabolism, Diabetes, and Cancer | Lifetime | 11 | US 8 | 99.89 |
| Diet and metabolism studies | Lifetime | 39 | US 20 | 99.88 |
| Diabetes Management and Research | Lifetime | 21 | US 11 | 99.84 |
| Diabetes Treatment and Management | Lifetime | 25 | US 14 | 99.85 |
| Electrolyte and hormonal disorders | Lifetime | 12 | US 6 | 99.68 |
| Pancreatic function and diabetes | Lifetime | 53 | US 29 | 99.74 |
| Adipose Tissue and Metabolism | Lifetime | 84 | US 47 | 99.73 |
| Pharmacology and Obesity Treatment | Lifetime | 16 | US 9 | 99.60 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 24 | US 12 | 99.38 |
| Muscle metabolism and nutrition | Lifetime | 60 | US 27 | 99.57 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 136 | US 64 | 99.41 |
| Metabolism and Genetic Disorders | Lifetime | 363 | US 164 | 98.62 |
| Diabetes and associated disorders | Lifetime | 254 | US 120 | 98.77 |
| Potassium and Related Disorders | Lifetime | 56 | US 37 | 98.70 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 530 | US 221 | 97.81 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 452 | US 219 | 97.03 |
| Diet, Metabolism, and Disease | Lifetime | 643 | US 232 | 97.07 |
| Neurological and metabolic disorders | Lifetime | 211 | US 93 | 95.74 |
| Regulation of Appetite and Obesity | Lifetime | 627 | US 274 | 96.57 |
| Ion Transport and Channel Regulation | Lifetime | 420 | US 220 | 96.33 |
| Biomedical Research and Pathophysiology | Lifetime | 703 | US 285 | 87.50 |
| Diabetes Treatment and Management | 2021-2025 | 341 | US 120 | 96.28 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 233 | US 64 | 92.95 |
| Diabetes Management and Research | 2021-2025 | 599 | US 238 | 93.41 |
| Pancreatic function and diabetes | 2021-2025 | 797 | US 269 | 88.67 |
| Pharmacology and Obesity Treatment | 2021-2025 | 186 | US 86 | 86.05 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 662 | US 239 | 67.46 |